Metraipolis › archive › dc_a0f8a702a64f

Double-seronegative neuromyelitis optica: it is possible to interrupt treatment after 10 years of stability — Europe PMC PMID:41638251

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41638251
DOI
10.1055/s-[numero omesso]
License (as archived)
solo-consultazione
Archived
2026-11-08T21:08:45.339Z
SHA-256 of the archived text
31f90106d164f750988313990372d300ce6bce39335666b6f2b6373f9082f43c
Stable URL of this page
https://metraipolis.com/documento/dc_a0f8a702a64f

How to cite

Double-seronegative neuromyelitis optica: it is possible to interrupt treatment after 10 years of stability — Europe PMC PMID:41638251 — Europe PMC (en), https://europepmc.org/article/MED/41638251 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a0f8a702a64f (Metraipolis archive dc_a0f8a702a64f, sha256 31f90106d164f750988313990372d300ce6bce39335666b6f2b6373f9082f43c)
BibTeX
@misc{dca0f8a702a64f,
  title = {Double-seronegative neuromyelitis optica: it is possible to interrupt treatment after 10 years of stability — Europe PMC PMID:41638251},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41638251},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a0f8a702a64f; sha256 31f90106d164f750988313990372d300ce6bce39335666b6f2b6373f9082f43c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41638251. Agents can read the archived copy with the MCP tool read_document.